Microdacyn60 Wound Care

Sonoma Pharmaceuticals Inc.

Boulder, CO, United States

Sonoma Pharmaceuticals is a global healthcare company dedicated to identifying, developing and commercializing unique differentiated therapies based on patented stabilized hypochlorous acid (HOCl). Sonoma Pharmaceutical s portfolio features a wide range of applications. Unique technology to help manage Wound Care and Dermatological discomforts like eczema, atopic dermatitis, acne, scars and eyelid disinfection. All products are MDR CE-approved class II Medical Devices. Unique Anti-inflammatory-, Antimicrobial-, pH Neutral-, non-Toxic and non-Cytotoxic technology that does not induce bacterial resistance. Sonoma s products assist the body in its natural healing process and are clinically-proven to reduce infections, itch, pain, scarring and harmful inflammatory responses safely and without damaging healthy tissue. Sonoma Pharmaceuticals has partnered with industry-leading partners in more than 21 countries in Europe and 55 countries globally, and is bringing to market unique evidence based, differentiated, patent-protected and high-quality FDA and CE-marked products that are affordable, efficacious and accessible to most every patient. The company wishes to expand its European business and is seeking new partners. If you have an interest in licensing Sonoma s patented Microcyn® Technology or distributing one or more Sonoma products, we are delighted to hear from you.